Remofuscin® prevented retinal thinning in Stargardt disease patients
Katairo GmbH, a biopharmaceutical company focused on discovering, developing and commercializing novel treatments for ba…
Katairo GmbH, a biopharmaceutical company focused on discovering, developing and commercializing novel treatments for ba…
The upcoming educational RF Lumination seminar series from Rohde & Schwarz shines a light on typical applications in the…
Radboud University Medical Center (RUMC) in Nijmegen, one of the largest centres of excellence in the Netherlands for ad…
Dr. Oliver Bärtl joins CorTec’s executive leadership team. Prof. Dr. Tim Denison, Prof. Dr. Pascal Fries, Dr. Christoph…
Medigene AG (FSE: MDG1, Prime Standard, TecDAX) today announced the appointment of eight leading experts to its new immu…
The European Pain Federation EFIC® in cooperation with the pharmaceutical company Grünenthal announced that six young re…
Xenikos B.V., focused on the development of innovative immunotherapies for the treatment of patients suffering from seri…
Xenikos B.V., focused on the development of innovative immunotherapies for the treatment of patients suffering from seri…
Xenikos B.V., focused on the development of innovative immunotherapies for the treatment of patients suffering from seri…
aap Implantate AG (“aap”) was able to achieve many of the targets that it set itself for the financial year 2015 and mad…